Jazz Pharmaceutical BUYOUT.How much would they pay to protect the 6.7 BILLION$$$ investment........measly little medipharm labs is the only threat to billions of highly profitable revenue through the sale of epidiolex and Sativex....I'm shure it's multiples higher than the present 20million canadian valuation given by the public market of a debt free 20+ mil cash on hand company....just ridiculous....